# Tirosint SOL

NDC: 71858-0145
Generic name: Levothyroxine Sodium
Labeler / Manufacturer: IBSA Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20190301

FDA application: NDA206977

## Active ingredients

- LEVOTHYROXINE SODIUM: 137 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71858-0145"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71858-0145
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d378add-f13d-40f2-99dc-0f2340ab44b7